PROPHASE LABS INC (PRPH)

Company Profile

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. The company is headquartered in New York City, New York and currently employs 129 full-time employees. The firm leverages its Clinical Laboratory Improvement Amendments (CLIA) lab services to provide whole genome sequencing and research direct to consumers and build a genomics database to be used for further research. The company provides traditional CLIA molecular laboratory services, including coronavirus disease (COVID-19) testing. The company also operates Pharmaloz, a contract manufacturing subsidiary, which offers the TK Supplements line of dietary supplements, which are distributed in food, drug, and mass stores. The firm's wholly owned subsidiary ProPhase Diagnostics, Inc, offers a broad array of clinical diagnostic and testing services at its CLIA-certified laboratories including polymerase chain reaction (PCR) testing for SARS-CoV-2 (COVID-19) and Influenza A and Influenza B. The company also owns the exclusive rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening test.

Company Info

PROPHASE LABS INC

711 Stewart Ave, Suite 200, Garden City

New York City NEW YORK 11530

P: 12153450919

CEO: Ted Karkus

Employees: 129

Website: https://www.prophaselabs.com/